Effects of lactic acid and glycolic acid on human osteoblasts: A way to understand PLGA involvement in PLGA/calcium phosphate composite failure

Journal of Orthopaedic Research

Volumn 30, Issue 6, 2012, Pages 864-871

  Meyer, Florent ^a   Wardale, John ^a   Best, Serena ^a   Cameron, Ruth ^a   Rushton, Neil ^a   Brooks, Roger ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Differentiation; Glycolic acid; Lactic acid; Osteoblast; PLGA

Indexed keywords

BIOPOLYMER; CALCIUM; CALCIUM PHOSPHATE; POLYGLACTIN;

ARTICLE; BONE MATRIX; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CERAMICS; CONTROLLED STUDY; DEGRADATION; DYNAMICS; FRACTURE HEALING; HUMAN; HUMAN CELL; IMPLANT; IN VITRO STUDY; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; CALCIUM PHOSPHATES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN TYPE I; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DRUG THERAPY, COMBINATION; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; GLYCOLATES; HUMANS; LACTIC ACID; OSSEOINTEGRATION; OSTEOBLASTS; OSTEOCALCIN; POLYGLYCOLIC ACID; PROSTHESIS DESIGN; PROSTHESIS FAILURE; TRANSCRIPTION FACTORS;

EID: 84859652585     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22019     Document Type: Article

References (32)

1. Wang W, Li B, Li Y, et al. 2010. In vivo restoration of fullthickness cartilage defects by poly(lactide-co-glycolide) sponges filled with fibrin gel, bone marrow mesenchymal stem cells and DNA complexes. Biomaterials 31:5953-5965.
2. Ngiam M, Liao SS, Patil AJ, et al. 2009. The fabrication of nano-hydroxyapatite on PLGA and PLGA/collagen nanofibrous composite scaffolds and their effects in osteoblastic behavior for bone tissue engineering. Bone 45:4-16.
3. Nie H, Ho ML, Wang CK, et al. 2009. BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice. Biomaterials 30:892-901.
4. Pippi D, Chiellini F, Piras AM, et al. 2010. Polymeric materials for bone and cartilage repair. Progr Polymer Sci 35:403-440.
5. Guoping Chen TU, Tetsuya T. 2002. Scaffold design for tissue engineering. Macromol Biosci 2:67-77.
6. Daculsi G, Laboux O, Malard O, et al. 2003. Current state of the art of biphasic calcium phosphate bioceramics. J Mater Sci Mater Med 14:195-200. (Pubitemid 36408018)
7. Weiler A, Hoffmann RF, Stahelin AC, et al. 2000. Biodegradable implants in sports medicine: The biological base. Arthroscopy 16:305-321. (Pubitemid 30196904)
8. Middleton JC, Tipton AJ. 2000. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 21:2335-2346.
9. Dujardin J, Vandenneucker H, Belleman J. 2008. Tibial cyst and intra-articular granuloma formation after anterior cruciate ligament reconstruction using polylactide carbonate osteoconductive interference screws. Arthroscopy 24:238-242. (Pubitemid 351163031)
10. Siebold R. 2007. Observations on bone tunnel enlargement after double-bundle anterior cruciate ligament reconstruction. Arthroscopy 23:291-298. (Pubitemid 46349534)
11. Dunne M, Corrigan I, Ramtoola Z. 2000. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials 21:1659-1668. (Pubitemid 30347308)
12. Yang Z, BSMaCRE. 2009. The influence of alpha-tricalcium phosphate nanoparticles and microparticles on the degradation of poly(D,L-lactide-co- glycolide). Adv Mater 21:3900-3904.
13. Ehrenfried LM, Patel MH, Cameron RE. 2008. The effect of tri-calcium phosphate (TCP) addition on the degradation of polylactide-co-glycolide (PLGA). J Mater Sci Mater Med 19:459-466.
14. Landes CA, Ballon A, Roth C. 2006. Maxillary and mandibular osteosyntheses with PLGA and P(L/DL)LA implants: A 5-year inpatient biocompatibility and degradation experience. Plast Reconstr Surg 117:2347-2360. (Pubitemid 44324279)
15. Hasirci V, Lewandrowski K, GresserJD, et al. 2001. Versatility of biodegradable biopolymers: Degradability and an in vivo application. J Biotechnol 86:135-150. (Pubitemid 32195455)
16. Noble BS. 2008. The osteocyte lineage. Arch Biochem Biophys 473:106-111.
17. Zayzafoon M. 2006. Calcium/calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem 97:56-70. (Pubitemid 43050179)
18. Sharan K, Siddiqui JA, Swarnkar G, et al. 2008. Role of calcium-sensing receptor in bone biology. Indian J Med Res 127:274-286. (Pubitemid 351936156)
19. Pamula E, Menaszek E. 2008. In vitro and in vivo degradation of poly(L: -lactide-co-glycolide) films and scaffolds. J Mater Sci Mater Med 19:2063-2070. (Pubitemid 351436311)
20. Bierer BE, Nathan DG. 1990. The effect of desferrithiocin, an oral iron chelator, on T-cell function. Blood 76:2052-2059.
21. Gharagozloo M, Khoshdel Z, Amirghofran Z. 2008. The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: A comparison with desferrioxamine. Eur J Pharmacol 589:1-7.
22. Green DA, Antholine WE, Wong SJ, et al. 2001. Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: Effect on the R2 subunit of ribonucleotide reductase. Clin Cancer Res 7:3574-3579. (Pubitemid 33069997)
23. Manning T, Kean G, Thomas J, et al. 2009. Iron chelators in medicinal applications - chemical equilibrium considerations in pharmaceutical activity. Curr Med Chem 16:2416-2429.
24. Cavasino FP, EDDaCS. 1982. Relaxation kinetic study of Iron(III) chelation with glycolic and lactic acids. Contribution of intermediate steps to the limiting rate in the overall process. Adv Mol Relax Int Pr 23:191-201.
25. Parat MO, Richard MJ, Meplan C, et al. 1999. Impairment of cultured cell proliferation and metallothionein expression by metal chelator N,N,N',N'-tetrakis-(2-pyridylmethyl)ethylene diamine. Biol Trace Elem Res 70:51-68. (Pubitemid 29422805)
26. Wang X. 1999. A theory for the mechanism of action of the alpha-hydroxy acids applied to the skin. Med Hypotheses 53:380-382.
27. Gerber I, Ap Gwynn I. 2001. Influence of cell isolation, cell culture density, and cell nutrition on differentiation of rat calvarial osteoblast-like cells in vitro. Eur Cell Mater 2:10-20. (Pubitemid 38904460)
28. Bitar M, Brown RA, Salih V, et al. 2008. Effect of cell density on osteoblastic differentiation and matrix degradation of biomimetic dense collagen scaffolds. Biomacromolecules 9:129-135. (Pubitemid 351201590)
29. Boskey AL, Chiang P, Fermanis A, et al. MEPE's diverse effects on mineralization. Calcif Tissue Int 86:42-46.
30. Addison WN, Nakano Y, Loisel T, et al. 2008. MEPEASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: An inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res 23:1638-1649.
31. Cho YD, Yoon WJ, Woo KM, et al. 2009. Molecular regulation of matrix extracellular phosphoglycoprotein expression by bone morphogenetic protein-2. J Biol Chem 284:25230-25240.
32. Yu YY, Lieu S, Lu C, et al. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair. Bone 46:841-851.